- Samuel A. Shelburne, Pranoti Sahasrabhojane, Miguel Saldana, Hui Yao, Xiaoping Su, Nicola Horstmann, Erika Thompson, Anthony R. Flores, “Streptococcus mitisStrains Causing Severe Clinical Disease in Cancer Patients”, Emerg. Infect. Dis., 20, № 5, 2014, 762
- Fuensanta Guerrero-Del-Cueto, Cyntia Ibanes-Gutiérrez, Consuelo Velázquez-Acosta, Patricia Cornejo-Juárez, Diana Vilar-Compte, “Microbiology and clinical characteristics of viridans group streptococci in patients with cancer”, The Brazilian Journal of Infectious Diseases, 22, № 4, 2018, 323
- Thomas Lehrnbecher, Lillian Sung, “Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia”, Expert Review of Hematology, 7, № 6, 2014, 819
- Arne Simon, Nora Gröger, Anja Wilkesmann, Carola Hasan, Gertrud Wiszniewsky, Steffen Engelhart, Michael H. Kramer, Udo Bode, Roland A. Ammann, Gudrun Fleischhack, “Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia”, International Journal of Antimicrobial Agents, 28, № 5, 2006, 417
- Anne F. Reilly, Beverly J. Lange, “Infections with viridans group streptococci in children with cancer”, Pediatric Blood & Cancer, 49, № 6, 2007, 774
- Sejong Chun, Hee Jae Huh, Nam Yong Lee, “Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci”, Ann Lab Med, 35, № 2, 2015, 205
- Kent A. Sepkowitz, “Treatment of Patients with Hematologic Neoplasm, Fever, and Neutropenia”, Clinical Infectious Diseases, 40, № Supplement_4, 2005, S253
- Andreas H. Groll, Arne Simon, Thomas Lehrnbecher, Pädiatrische Hämatologie und Onkologie, 2006, 978
- Thomas J Pallasch, “Antibiotic resistance”, Dental Clinics of North America, 47, № 4, 2003, 623
- Chia-Ter Chao, Szu-Ying Lee, Wei-Shun Yang, Huei-Wen Chen, Cheng-Chung Fang, Chung-Jen Yen, Chih-Kang Chiang, Kuan-Yu Hung, Jenq-Wen Huang, “Viridans Streptococci in Peritoneal Dialysis Peritonitis: Clinical Courses and Long-Term Outcomes”, Perit Dial Int, 35, № 3, 2015, 333